These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2935624)

  • 41. Atriopeptin release in conditions of altered salt and water balance in the rat.
    Schwartz D; Katsube NC; Needleman P
    Biochem Biophys Res Commun; 1986 Jun; 137(3):922-8. PubMed ID: 2942144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of atriopeptin in the hypotensive effect of dynorphin].
    Yin LY; Xie XZ; Gao XM; Xia ZQ; Xie CW; Tang J
    Sheng Li Xue Bao; 1988 Aug; 40(4):343-8. PubMed ID: 2907825
    [No Abstract]   [Full Text] [Related]  

  • 43. Pulmonary clearance of atrial natriuretic peptides.
    Numan NA; Gillespie MN; Altiere RJ
    Pulm Pharmacol; 1990; 3(1):25-8. PubMed ID: 2152026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central nervous system mediated vasodepressor action of atrial natriuretic factor.
    Levin ER; Mills S; Weber MA
    Life Sci; 1989; 44(22):1617-24. PubMed ID: 2525218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms underlying atriopeptin-induced increases in hematocrit and vascular permeation in rats.
    Williamson JR; Holmberg SW; Chang K; Marvel J; Sutera SP; Needleman P
    Circ Res; 1989 May; 64(5):890-9. PubMed ID: 2523261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythropoietin kinetics in rats: generation and clearance.
    Steinberg SE; Garcia JF; Matzke GR; Mladenovic J
    Blood; 1986 Mar; 67(3):646-9. PubMed ID: 3947741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Distribution of I-125-atriopeptin III in the internal organs of rats].
    Kalenikova EI; Zhukovskiĭ SV; Blidchenko IuA; Vinogradov VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):111-4. PubMed ID: 2962586
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of atriopeptin III on membrane potential and intracellular Ca++-activity in rat glioma cells.
    Reiser G; Höpp HP; Hamprecht B
    Regul Pept Suppl; 1985; 4():101-3. PubMed ID: 2932772
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of hemorrhage on plasma atriopeptin levels in conscious dogs.
    Geer PG; Wang BC; Flora-Ginter G; Leadley RJ; Goetz KL
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):327-34. PubMed ID: 2964642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that atriopeptin is not a physiological regulator of sodium excretion.
    Goetz KL
    Hypertension; 1990 Jan; 15(1):9-19. PubMed ID: 2136844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronotropic and inotropic effects of atrial peptides on the isolated systemic heart of Octopus vulgaris.
    Agnisolo C; Cariello L; De Santis A; Miralto A; Tota B
    J Comp Physiol B; 1989; 158(6):637-41. PubMed ID: 2523916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of atriopeptin and angiotensin on the rat right ventricle.
    Doggrell SA
    Gen Pharmacol; 1989; 20(2):253-7. PubMed ID: 2523836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings: Kinetics of distribution and elimination of a basic lipophilic drug metabolite in the rat.
    Breyer U; Vïllumsen K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R13. PubMed ID: 4152358
    [No Abstract]   [Full Text] [Related]  

  • 55. Concentration-response relations for apomorphine effects on heart rate in conscious rats.
    Paalzow LK; Paalzow GH
    J Pharm Pharmacol; 1986 Jan; 38(1):28-34. PubMed ID: 2869123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-dose ceftriaxone kinetics in functionally anephric patients.
    Stoeckel K; McNamara PJ; Hoppe-Seyler G; Blumberg A; Keller E
    Clin Pharmacol Ther; 1983 May; 33(5):633-41. PubMed ID: 6301740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas.
    Saper CB; Standaert DG; Currie MG; Schwartz D; Geller DM; Needleman P
    Science; 1985 Mar; 227(4690):1047-9. PubMed ID: 2858127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atriopeptin III degradation by endopeptidase 24.11: the Cys-Phe bond is not the preferential cleavage site.
    Nortier J; Pauwels S; De Prez E; Deschodt-Lanckman M
    Peptides; 1993; 14(2):405-8. PubMed ID: 8483817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of partial nephrectomy on the pharmacokinetics and pharmacodynamics of recombinant human erythropoietin (SNB-5001) in rats].
    Masunaga H; Takahira R; Kohsaka K; Sawai T
    Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):205-11. PubMed ID: 1607130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and pharmacodynamics of the stable prostacyclin analogue, ZK 36 374, in the cat.
    Krause W; Beckmann R; Schubert M
    Prostaglandins Leukot Med; 1984 Aug; 15(2):187-97. PubMed ID: 6208562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.